Medicine and Dentistry
Patient
92%
Parkinson's Disease
72%
Fluorine-18
67%
Tau
56%
Positron Emission Tomography
42%
Alzheimer's Disease
34%
Brain
23%
Dopamine Agonist
23%
Amyloid
23%
Inpatient
19%
Magnetic Resonance Imaging
19%
Parkinsonism
19%
Flortaucipir
18%
Standardized Uptake Value
18%
Age
14%
Unified Parkinson's Disease Rating Scale
14%
Association
13%
Gait
13%
Carbon 11
12%
Neurology
12%
Dopamine
12%
Drug
11%
Chemotherapeutic Agent
11%
Mild Cognitive Impairment
11%
Putamen
11%
Cognitive Defect
10%
Mitochondrial Membrane Transport Protein
10%
Deterioration
10%
Monoamine
9%
Dopamine Transporter
9%
Temporal Lobe
9%
Time Perception
9%
Perceptive Discrimination
9%
Thalamus
8%
Symptom
8%
Basal Ganglia
8%
Dementia
8%
Globus pallidus
7%
Florbetaben (18F)
7%
Bradykinesia
7%
Pathology
7%
DNA Template
7%
Progressive Supranuclear Palsy
7%
Tremor
7%
Analysis
6%
Nortropane Derivative
6%
Cerebellum
6%
Iodine 123
6%
Finger
6%
Hospital
6%
Neuroscience
Parkinson's Disease
100%
Amyloid
28%
Dopaminergic
27%
Positron Emission Tomography
23%
Cognitive Disorders
20%
Brain
20%
Positron Emission Tomography
17%
Translocator Protein
14%
Gait
13%
Dementia
13%
Magnetic Resonance Imaging
12%
Dopamine
11%
L-DOPA
10%
Temporal Lobe
10%
Amyloid
9%
Mild Cognitive Impairment
9%
Putamen
9%
Positron Emission Tomography
9%
Parkinsonism
9%
Alzheimer's Disease
7%
Neurodegeneration
7%
Radioligand
7%
Dopamine Transporter
6%
Genotype
6%
Frontal Variant Frontotemporal Dementia
6%
Dyskinesia
6%
Entorhinal Cortex
5%
Cognition
5%
Dystonia
5%
DNA Template
5%
Mild Cognitive Impairment
5%
Gene
5%
Striatum
5%
Monoamine
5%
Bradykinesia
5%